Inoviq LtdASX: IIQ

INOVIQ receives $1.782m R&D Tax Incentive Refund

· Issued by Inoviq Ltd via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

The company incurred substantial expenses on eligible R&D activities and was able to claim this refund under the Australian Government’s R&D Tax Incentive program. This announcement highlights INOVIQ's ongoing commitment to advancing exosome-based diagnostics and therapeutics in cancer care.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/inoviq-receives-dollar1.782m-randd-tax-incentive-refund

Release

ASX Announcement INOVIQ RECEIVES $1.782M R&D TAX INCENTIVE REFUND Melbourne, Australia, 26 October 2026: INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a biotechnology company developing next-generation exosome-based diagnostics and therapeutics, is pleased to announce that it has received a...

Inoviq Ltd on 6ix

Earlier from Inoviq

Later from Inoviq

All Inoviq news releases